Abstract:Objective: An earlier three-way crossover study evaluating bioequivalence of 3 cefalexin formulations (capsule for reference, capsule and tablet for test) in healthy subjects in Malaysia showed that the intra-individual coefficients of variation were 9.25% for AUC(0-t), 9.54% for AUC(0-8), and 13.90% for C-max. It is preliminarily stated that cefalexin is not a high-variation product. The here-presented clinical study in China was carried out to analyze the pharmacokinetic properties of two preparations in fasting and postprandial condition to assess the bioequivalence of the test preparation and reference preparation when administered on a fasting and postprandial basis in healthy Chinese subjects and to observe the safety of the test preparation and reference preparation in healthy Chinese subjects. Materials and methods: In this trial, a total of 56 eligible subjects were randomly assigned to the fasting group and the postprandial group. The two groups were given 250 mg of the test and reference preparation, respectively. Liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was applied to determine the plasma concentration of cefalexin. PhoenixWinNonlin software (V7.0) was used to calculate the pharmacokinetic parameters of cefalexin using the non-compartmental model (NCA), and the bioequivalence and safety results were calculated by SAS (V9.4) software. Results: The main pharmacokinetic parameters of the test and reference preparations were as follows, the fasting group: C-max 12.59 +/- 2.65 mu g/mL, 12.72 +/- 2.28 mu g/mL; AUC(0-8h) 20.43 +/- 3.47 hx mu g/mL, 20.66 +/- 3.38 hx mu g/mL; AUC(0-8) 20.77 +/- 3.53 hx mu g/mL, 21.02 +/- 3.45 hx mu g/mL; the postprandial group: Cmax 5.25 +/- 0.94 mu g/mL, 5.23 +/- 0.80 mu g/mL; AUC(0-10h) 16.92 +/- 2.03 hx mu g/mL, 17.09 +/- 2.31 hx mu g/mL; AUC(0-8) 17.33 +/- 2.09 hx mu g/mL, 17.67 +/- 2.45 hx mu g/mL. Conclusion: The 90% confidence intervals of geometric mean ratios of test preparation and reference preparation were calculated, and the 90% confidence intervals of geometric mean ratios of Cmax, AUC(0-10h), and AUC(0-8) were within the 80.00% similar to 125.00% range in both groups. Both Cmax and AUC met the pre-determined criteria for assuming bioequivalence. The test and reference products were bioequivalent after administration under fasting as well as under fed conditions in healthy Chinese subjects. This study may suggest that successful generic versions of cefalexin not only guarantee the market supply of such drugs but can also improve the safety and effectiveness and quality controllability of cefalexin through a new process and a new drug composition ratio.

Pharmacokinetics and Bioequivalence Study of Cefdinir Suspension in Healthy Volunteers

Bioequivalence of domestic and imported Cefdinir Granule in healthy volunteers

Pharmacokinetics and Bioequivalence of Cefdinir Dispersible Tablet in Healthy Volunteers

Bioequivalence of cefdinir dispersible tablets in healthy Chinese subjects under fasting and fed conditions: a single-centred, randomized, open, single-dose, two-preparation, two-cycle, two-sequence, double-crossover trial

Pharmacokinetics and Bioequivalence Study of Cefixime Tablet in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

The Bioequivalence of Cefpodoxime Oral Suspension in Healthy Volunteers

Bioavailability of Cefuroxime Axetii Suspension in Healthy Volunteers

Bioequivalence of Cefalexin in Healthy Chinese Subjects

Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states

An LC-MS/MS method for simultaneous determination of cefprozil diastereomers in human plasma and its application for the bioequivalence study of two cefprozil tablets in healthy Chinese volunteers.

An Open‐Label, Randomized, 2‐way, Crossover Bioequivalence Study of Cefradine Capsules in Healthy Chinese Volunteers

Selective method for the determination of cefdinir in human plasma using liquid chromatography electrospray ionization tandam mass spectrometry.

Clinical Pharmacokinetics of Cefprozil and Bioequivalence Between Its Tablet and Suspension

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

A Study of the Bioequivalence of Fleroxacin Tablets in Healthy Chinese Volunteers

Pharmacokinetic and bioequivalence studies of ibuprofen suspension after a single-dose administration in healthy Chinese volunteers.

Pharmacokinetic and Bioequivalence Evaluation of Two Cefprozil Dispersible Tablets in Healthy Chinese Volunteers

Relative Bioavailability of Cefadroxil in Healthy Volunteers

Bioequivalence Study of Two Formulations of Cefixime

Bioequivalence Study of Erythromycin Cyclic 11,12-Carbonate Powder Suspension,capsule and Tablet